Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amplicons as vaccine vectors.

Kathlyn Santos1, Cindy M P Duke, Stephen Dewhurst

  • 1University of Rochester, Medical Center, Rochester, NY 14642, USA.

Current Gene Therapy
|June 22, 2006
PubMed
Summary

HSV-1 amplicon vectors show promise for developing vaccines against cancer and infectious diseases. These vectors efficiently deliver genetic material to antigen-presenting cells, enhancing immune responses without impairing cell function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constitutive NF-kB Activation Is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells That Resist Viral Oncolysis.

Viruses·2026
Same author

QuickDraw: detecting HIV in whole blood using an integrated paper-based consumable that enables direct amplification of purified RNA from paper.

Lab on a chip·2026
Same author

LAIV Mutations Selectively Alter Influenza Viral RNA Polymerase Function, Favoring Transcription over Genome Synthesis.

Viruses·2025
Same author

Constitutive NF-κB Activation is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells that Resist Viral Oncolysis.

bioRxiv : the preprint server for biology·2025
Same author

Antibody Responses to SARS-CoV-2 and Common HCoVs in Hemodialysis Patients and Transplant Recipients: Data from the Dominican Republic.

Vaccines·2025
Same author

Subcellular localization of SARS-CoV-2 E and 3a proteins along the secretory pathway.

Journal of molecular histology·2025

Area of Science:

  • Molecular Biology
  • Immunology
  • Vaccinology

Background:

  • Herpes Simplex Virus-1 (HSV-1) amplicon vectors are effective tools for gene delivery.
  • Antigen-presenting cells (APCs), including dendritic cells and B cells, are key targets for vaccine development.

Purpose of the Study:

  • To evaluate the potential of HSV-1 amplicon vectors as vaccine delivery platforms.
  • To assess the efficacy of amplicon vectors in preclinical models for cancer and infectious diseases.

Main Methods:

  • Transduction of human and murine APCs with helper-free HSV-1 amplicon vectors.
  • In vivo studies using amplicon vectors encoding immunomodulatory cytokines (IL-2, GM-CSF) or CD40L in cancer models.
  • Assessment of immune responses against encoded antigens, such as HIV-1 antigens in mice.

Main Results:

  • Efficient transduction of APCs, including dendritic cells and chronic lymphocytic leukemia (CLL) B cells, without impairing their antigen-presenting functions.
  • Preclinical studies demonstrated protective responses against tumor challenge and slowed tumor growth or eradication.
  • Generation of strong cellular immune responses against encoded antigens in mouse models.

Conclusions:

  • HSV-1 amplicon vectors demonstrate significant promise as versatile vaccine vectors.
  • Further studies are warranted to evaluate immunogenicity in diverse animal models, including nonhuman primates.
  • Amplicon vectors offer advantages such as large transgene capacity and efficient mucosal transduction, requiring further investigation.

Related Experiment Videos